1,2-Dichloroethane → 4-Amino-N-(1-azabicyclo[2.2.2]oct-3-yl)-3-iodobenzamide

HRID 1516789

Reaktionsgleichung

Reaktionsgleichung von HRID 1516789
Cl.Cl.[NH2:3][CH:4]1[CH:9]2[CH2:10][CH2:11][N:6]([CH2:7][CH2:8]2)[CH2:5]1.[NH2:12][C:13]1[CH:21]=[CH:20][C:16]([C:17](O)=[O:18])=[CH:15][C:14]=1[I:22].C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl.C(N(CC)C(C)C)(C)C>CN(C=O)C.O>[NH2:12][C:13]1[CH:21]=[CH:20][C:16]([C:17]([NH:3][CH:4]2[CH:9]3[CH2:10][CH2:11][N:6]([CH2:7][CH2:8]3)[CH2:5]2)=[O:18])=[CH:15][C:14]=1[I:22]

Komponenten

8

Versuchsvorschrift

A solution of 2.04 g (10.3 mmol) of 3-aminoquinuclidine dihydrochloride, 2.70 g (10.3 mmol) of 4-amino-3-iodobenzoic acid, 1.39 g (10.3 mmol) of HOBt, 2.16 g (11.3 mmol) of EDC and 6.63 g (51.3 mmol) of N,N-diisopropylethylamine in 150 ml of DMF was stirred at room temperature for 16 h. 300 ml of water were added, and the aqueous phase was extracted three times with 300 ml of ethyl acetate each time. The combined organic phases were dried over sodium sulfate and the solvent was distilled off in vacuo. The residue was purified on a flash column (mobile phase: dichloromethane/methanol/triethylamine 90:10:0.2). 3.45 g (87%) of the desired title compound were obtained.

Aufarbeitung

  1. extractionthe aqueous phase was extracted three times with 300 ml of ethyl acetate each time
  2. dry with materialThe combined organic phases were dried over sodium sulfate
  3. distillationthe solvent was distilled off in vacuo
  4. customThe residue was purified on a flash column (mobile phase: dichloromethane/methanol/triethylamine 90:10:0.2)

Quellen und Nachweise

ORD-Eintrag
ord-239119d2072849c995741bb197d2ae70
Quelldatensatz
uspto-grants-2012_07
Patentnummer
US08227598B2

Verknüpfte Notizen

Wird geladen…